Principal Financial Group Inc Avid Bioservices, Inc. Transaction History

Principal Financial Group Inc

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 29, 2024	BUY	$6.34 - $9.28 $70,760 - $103,574	11,161 New	11,161 $79,000
Q4 2023 Feb 07, 2024	SELL	$4.64 - $9.56 $1.51 Million - $3.11 Million	-325,301 Reduced 94.98%	17,205 $111,000
Q3 2023 Nov 02, 2023	SELL	$9.4 - $14.04 $170,140 - $254,123	-18,100 Reduced 5.02%	342,506 $3.23 Million
Q2 2023 Aug 07, 2023	SELL	$12.96 - $20.93 $349,958 - $565,172	-27,003 Reduced 6.97%	360,606 $5.04 Million
Q1 2023 May 09, 2023	SELL	$13.48 - $18.79 $134,975 - $188,144	-10,013 Reduced 2.52%	387,609 $7.27 Million
Q4 2022 Feb 09, 2023	BUY	$12.61 - $18.74 $181,483 - $269,706	14,392 Added 3.76%	397,622 $5.48 Million
Q3 2022 Nov 09, 2022	SELL	$15.33 - $20.36 $62,791 - $83,394	-4,096 Reduced 1.06%	383,230 $7.33 Million
Q2 2022 Aug 10, 2022	SELL	$11.63 - $21.55 $794,689 - $1.47 Million	-68,331 Reduced 15.0%	387,326 $5.91 Million
Q1 2022 May 09, 2022	SELL	$16.63 - $27.73 $286,285 - $477,371	-17,215 Reduced 3.64%	455,657 $9.28 Million
Q4 2021 Feb 09, 2022	BUY	$20.7 - $34.18 $7.99 Million - $13.2 Million	386,148 Added 445.26%	472,872 $13.8 Million
Q3 2021 Nov 09, 2021	BUY	$19.05 - $28.32 $5,924 - $8,807	311 Added 0.36%	86,724 $1.87 Million
Q2 2021 Aug 10, 2021	BUY	$18.93 - $25.65 $1.4 Million - $1.9 Million	74,199 Added 607.49%	86,413 $2.22 Million
Q1 2021 May 10, 2021	SELL	$11.86 - $21.77 $12,464 - $22,880	-1,051 Reduced 7.92%	12,214 $223,000
Q4 2020 Feb 08, 2021	BUY	$7.25 - $11.76 $96,171 - $155,996	13,265 New	13,265 $153,000

177

68.4M

21.3K

110K

Ticker CDMO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,167,500
Market Cap $683M
Description
Avid Bioservices, Inc., a contract development and manufacturing organization, provides process development and current good manufacturing practices (CGMP) clinical and commercial manufacturing services focused on biopharmaceutical drug substances derived from mammalian cell culture. The company produces monoclonal antibodies and recombinant pro...

Get notified when there are updates to the investment portfolio of Principal Financial Group Inc, based on Form 13F filings with the SEC.

Stay updated on Principal Financial Group Inc with notifications on news.